Correlation Between Edgewise Therapeutics and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Akari Therapeutics PLC, you can compare the effects of market volatilities on Edgewise Therapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Akari Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Akari Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Akari is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Akari Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.89 times more return on investment than Akari Therapeutics. However, Edgewise Therapeutics is 1.12 times less risky than Akari Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.01 per unit of risk. If you would invest 1,029 in Edgewise Therapeutics on August 31, 2024 and sell it today you would earn a total of 2,271 from holding Edgewise Therapeutics or generate 220.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.73% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Edgewise Therapeutics |
| Akari Therapeutics PLC |
Edgewise Therapeutics and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Akari Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Molecular Partners AG |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |